Article Versions Notes

Suominen MI, Knuuttila M, Sjöholm B, Wilson T, Alhoniemi E, Mumberg D, Käkönen S-M, Scholz A. Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model. Cancers. 2023; 15(16):4115. https://doi.org/10.3390/cancers15164115

Suominen, Mari I., Matias Knuuttila, Birgitta Sjöholm, Timothy Wilson, Esa Alhoniemi, Dominik Mumberg, Sanna-Maria Käkönen, and Arne Scholz. 2023. "Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model" Cancers 15, no. 16: 4115. https://doi.org/10.3390/cancers15164115

Suominen, M. I., Knuuttila, M., Sjöholm, B., Wilson, T., Alhoniemi, E., Mumberg, D., Käkönen, S.-M., & Scholz, A. (2023). Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model. Cancers, 15(16), 4115. https://doi.org/10.3390/cancers15164115